CRWV enters the week having reversed course sharply — shares borrowed against the stock have exploded back to levels last seen at the early-September peak, even as the price has quietly recovered.
The short-side story has flipped completely since last week's note. The last note logged borrowed shares at around 48,700, following a sharp unwind from the September highs. That covering has now reversed with force. Borrowed shares climbed nearly 390% over the past five trading days, from roughly 48,700 to 237,258 by September 21. Month-over-month the build is even more striking — up over 2,700% from the 8,400 shares recorded in mid-August. This is not incremental repositioning. It is a wholesale return of short interest to a stock that appeared to have been largely abandoned by bears just a fortnight ago.
Borrowing costs have eased slightly, which adds a wrinkle to the narrative. Cost to borrow fell roughly 20% over the week to 4.19%, after touching 5.23% on September 11. That pullback in the rate at which lenders charge for access to shares suggests the initial demand shock has been partially absorbed — lenders have made more supply available, or the rush to establish new short positions has stabilised for now. The ORTEX short score has risen alongside the renewed positioning, climbing from 27.3 to 29.3 over the past week. That remains a relatively low absolute reading, ranking only in the 11th percentile of the broader universe, so this is a build from a low base rather than a sign that CRWV is turning into a heavily-contested short. Still, the direction of travel is unambiguous — the short-side is rebuilding with unusual speed.
The price reaction complicates the bear thesis. Despite the rapid reconstruction of borrowed shares, CRWV rose 5% on September 21 alone and added nearly 3% over the week to close around CAD 16.12. The stock has given back only 3% over the past month — a modest drawdown by the standards of AI infrastructure names that have seen sharper swings. Shorts rebuilding into a rising stock are paying a carry cost of around 4.2% annualised and so far getting the price wrong. The last earnings print in August delivered a 22% single-day gain, a reminder that this stock can move violently when results arrive.
The institutional picture offers some context. BlackRock added over 14.7 million shares as last reported through August, and Vanguard entities have also been adding. Michael Intrator, the CEO, remains the largest disclosed holder at around 9.5% of shares, though his stake fell by 3.4 million shares per the September 15 filing — a reduction worth monitoring given the timing of the short rebuild. The ORTEX analyst recommendation differential ranks in the 99th percentile, meaning the Street is more bullish on CRWV relative to peers than on almost any other name in the database. That level of analyst conviction, set against a sharp short rebuild and insider trimming, describes the tension the market is navigating.
With the next earnings event not until November 12, the next test for this positioning is whether the short rebuild continues to accelerate or fades again — as it did twice already in September — and whether the price holds above the CAD 15-16 range that has contained recent weakness.
See the live data behind this article on ORTEX.
Open CRWV on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
